NeoGenomics (NASDAQ: NEO) and Intertek Group (OTCMKTS:IKTSY) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends and valuation.
Risk and Volatility
NeoGenomics has a beta of 0.42, suggesting that its share price is 58% less volatile than the S&P 500. Comparatively, Intertek Group has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500.
This is a breakdown of recent ratings and target prices for NeoGenomics and Intertek Group, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
NeoGenomics currently has a consensus price target of $17.29, suggesting a potential upside of 114.73%. Given NeoGenomics’ higher possible upside, research analysts plainly believe NeoGenomics is more favorable than Intertek Group.
Intertek Group pays an annual dividend of $0.78 per share and has a dividend yield of 1.2%. NeoGenomics does not pay a dividend. Intertek Group pays out 31.6% of its earnings in the form of a dividend.
Earnings & Valuation
This table compares NeoGenomics and Intertek Group’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Intertek Group||$3.57 billion||2.98||$370.29 million||$2.47||26.66|
Intertek Group has higher revenue and earnings than NeoGenomics. Intertek Group is trading at a lower price-to-earnings ratio than NeoGenomics, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
84.6% of NeoGenomics shares are owned by institutional investors. Comparatively, 0.0% of Intertek Group shares are owned by institutional investors. 11.2% of NeoGenomics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
This table compares NeoGenomics and Intertek Group’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. This segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. It has laboratory locations in Ft. Myers and Tampa, Florida; Aliso Viejo, Fresno, Irvine, and West Sacramento, California; Houston, Texas and Nashville, and Tennessee. It offers testing services, which include Cytogenetics, Fluorescence In-Situ Hybridization (FISH), Flow cytometry, Immunohistochemistry (IHC), Molecular testing and Pathology consultation. Its Pharma Services and Clinical Trials group provides testing services in support of its pharmaceutical clients’ oncology programs from discovery to commercialization. It helps its customers develop a biomarker hypothesis by recommending an optimal platform for molecular screening and backing its discovery tools with the informatics to capture meaningful data.
About Intertek Group
Intertek Group Plc provides quality and safety solutions to various industries worldwide. It operates in three segments: Products, Trade, and Resources. The Products segment offers assurance, testing, and inspection and certification services (ATIC), including laboratory safety, quality and performance testing, second-party supplier auditing, sustainability analysis, products assurance, vendor compliance, process performance analysis, facility plant and equipment verification, and third party certification services. This segment serves a range of industries including textiles, footwear, toys, hard lines, home appliances, consumer electronics, information and communication technology, automotive, aerospace, lighting, building products, industrial and renewable energy products, food and hospitality, healthcare and beauty, and pharmaceuticals. The Trade segment provides cargo inspection, analytical assessment, calibration, and related research and technical services to the petroleum and biofuels industries; inspection services to governments and regulatory bodies to support trade activities; and analytical and testing services to agricultural trading companies and growers. The Resources segment offers technical inspection, asset integrity management, analytical testing, and ongoing training services for oil, gas, nuclear, and power industries. This segment also provides a range of ATIC solutions to the mining and minerals exploration industries covering the resource supply chain. The company also offers cyber security services for products, equipment, and networks across various industries. Intertek Group Plc was founded in 1885 and is based in London, the United Kingdom.
Receive News & Ratings for NeoGenomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeoGenomics and related companies with MarketBeat.com's FREE daily email newsletter.